Medicine labels and government guidance
Cold storage is product-specific
Storage guidance checked September 17, 2026 differs between peptide medicines: some need refrigeration, while others use room-temperature storage.
Follow the product label and the pharmacy’s storage instructions; peptide medicines do not all share one cold-storage rule.
Read the semaglutide storage informationIf a refrigerated weight medicine arrives warm
The US government agency that reviews medicines for approval is called the Food and Drug Administration (FDA).
GLP-1 is a body substance that helps control blood sugar and appetite.
The name is also used for medicines that act like that body substance.
FDA guidance checked September 17, 2026 advises against using injectable GLP-1 medicine delivered warm or with too little refrigeration.
The FDA says insufficient refrigeration can affect the medicine’s quality.
- Tell the pharmacy how the package arrived.
- Ask it to address the storage concern before relying on the product.
FDA alert
The name on the label needs checking
As checked September 26, 2026, the FDA had found fraudulent compounded semaglutide and tirzepatide labels naming nonexistent pharmacies or pharmacies that did not make the product.
Compounded means made or mixed to order.
Compare the name with the state licence record and the paperwork you were given.
Read the FDA’s label concernsIf the directions are hard to understand
The FDA’s reports checked September 26, 2026 include hospital care after dose errors involving compounded semaglutide injections.
Ask the pharmacist to explain the written directions before using the medicine.
- Which written instructions belong to this exact product?
- What storage conditions and discard date apply?
- Who can answer a question about the prescription itself?